1. Arnold, M, Sierra, MS, Laversanne, M, et al. (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683–691.
2. Chen, W, Zheng, R, Baade, PD, et al. (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66, 115–132.
3. Vancamelbeke, M & Vermeire, S (2017) The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterology Hepatol 11, 821–834.
4. Specian, RD & Oliver, MG (1991) Functional biology of intestinal goblet cells. Am J Physiol 260, C183–C193.
5. Betge, J, Schneider, NI, Harbaum, L, et al. (2016) MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. Virchows Arch 469, 255–265.
6. John, R, El-Rouby, NM, Tomasetto, C, et al. (2007) Expression of TFF3 during multistep colon carcinogenesis. Histol Histopathol 22, 743–751.
7. Turksen, K & Troy, TC (2011) Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta 1816, 73–79.
8. Wang, X, Tully, O, Ngo, B, et al. (2011) Epithelial tight junctional changes in colorectal cancer tissues. Scientific World Journal 11, 826–841.
9. Huo, Q, Kinugasa, T, Wang, L, et al. (2009) Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res 29, 851–857.
10. Wells, JM, Brummer, RJ, Derrien, M, et al. (2017) Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol 312, G171–G193.
11. Diakos, CI, Charles, KA, McMillan, DC, et al. (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15, e493–e503.
12. Silva, EO & Bracarense, APFRL (2016) Phytic acid: from antinutritional to multiple protection factor of organic systems. J Food Sci 81, R1357–R1362.
13. Graf, E, Empson, KL & Eaton, JW (1987) Phytic acid. A natural antioxidant. J Biol Chem 262, 11647–11650.
14. Graf, E & Eaton, JW (1985) Dietary suppression of colonic cancer. Fiber or phytate? Cancer 56, 717–718.
15. Nawrocka-Musial, D & Latocha, M (2012) [Phytic acid – anticancer nutriceutic]. Pol Merkur Lekarski 33, 43–47.
16. Druzijanic, N, Juricic, J, Perko, Z, et al. (2004) IP6 + inositol as adjuvant to chemotherapy of colon cancer: our clinical experience. Anticancer Res 24, 3474.
17. Latifah, SY, Armania, N, Tze, TH, et al. (2010) Germinated brown rice (GBR) reduces the incidence of aberrant crypt foci with the involvement of beta-catenin and COX-2 in azoxymethane-induced colon cancer in rats. Nutr J 9, 16.
18. Norazalina, S, Norhaizan, ME, Hairuszah, I, et al. (2010) Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats. Exp Toxicol Pathol 62, 259–268.
19. Henderson, AJ, Ollila, CA, Kumar, A, et al. (2012) Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr 3, 643–653.
20. Okazaki, Y & Katayama, T (2014) Dietary phytic acid modulates characteristics of the colonic luminal environment and reduces serum levels of proinflammatory cytokines in rats fed a high-f at diet. Nutr Res 34, 1085–1091.
21. Pacheco, GD, Silva, CA, Pinton, P, et al. (2012) Phytic acid protects porcine intestinal epithelial cells from deoxynivalenol (DON) cytotoxicity. Exp Toxicol Pathol 64, 345–347.
22. Fu, Q, Wang, H, Xia, M, et al. (2015) The effect of phytic acid on tight junctions in the human intestinal Caco-2 cell line and its mechanism. Eur J Pharm Sci 80, 1–8.
23. Reeves, PG, Nielsen, FH & Fahey, GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939–1951.
24. Saad, N, Esa, NM & Ithnin, H (2013) Suppression of β-catenin and cyclooxygenase-2 expression and cell proliferation in azoxymethane-induced colonic cancer in rats by rice bran phytic acid (PA). Asian Pac J Cancer Prev 14, 3093–3099.
25. Kufe, DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9, 874–885.
26. Velcich, A, Yang, W, Heyer, J, et al. (2002) Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295, 1726–1729.
27. Shan, YS, Hsu, HP, Lai, MD, et al. (2014) Suppression of mucin 2 promotes interleukin-6 secretion and tumor growth in an orthotopic immune-competent colon cancer animal model. Oncol Rep 32, 2335–2342.
28. Kuugbee, ED, Shang, X, Gamallat, Y, et al. (2016) Structural change in microbiota by a probiotic cocktail enhances the gut barrier and reduces cancer via TLR2 signaling in a rat model of colon cancer. Dig Dis Sci 61, 2908–2920.
29. Barcelo, A, Claustre, J, Moro, F, et al. (2000) Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 46, 218–224.
30. Shimotoyodome, A, Meguro, S, Hase, T, et al. (2000) Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon. Comp Biochem Physiol A Mol Integr Physiol 125, 525–531.
31. Podolsky, DK, Lynch-Devaney, K, Stow, JL, et al. (1993) Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268, 12230.
32. Longman, RJ, Douthwaite, J, Sylvester, PA, et al. (2000) Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 47, 792–800.
33. Uchino, H, Kataoka, H, Itoh, H, et al. (1997) Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas. J Clin Pathol 50, 932–934.
34. Uchino, H, Kataoka, H, Itoh, H, et al. (1999) Roles of intestinal trefoil factor (ITF) in human colorectal cancer: ITF suppresses the growth of colorectal carcinoma cells. Hum Cell 12, 181–188.
35. Taupin, D & Podolsky, DK (2003) Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4, 721–732.
36. Pope, JL, Ahmad, R, Bhat, AA, et al. (2014) Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis. Mol Cancer 13, 167.
37. Grone, J, Weber, B, Staub, E, et al. (2007) Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12. Int J Colorectal Dis 22, 651–659.
38. Kinugasa, T, Huo, Q, Higashi, D, et al. (2007) Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 27, 3729–3734.
39. Pope, JL, Bhat, AA, Sharma, A, et al. (2014) Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut 63, 622–634.
40. Kinugasa, T, Akagi, Y, Yoshida, T, et al. (2010) Increased claudin-1 protein expression contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer. Anticancer Res 30, 3181–3186.
41. Shiozaki, H, Oka, H, Inoue, M, et al. (1996) E-cadherin mediated adhesion system in cancer cells. Cancer 77, 1605–1613.
42. Ngan, CY, Yamamoto, H, Seshimo, I, et al. (2007) A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer. J Surg Oncol 95, 652–662.
43. Heuberger, J & Birchmeier, W (2009) Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling. Cold Spring Harb Perspect Biol 2, a002915.
44. Konze, SA, van Diepen, L, Schröder, A, et al. (2014) Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells. Mol Cell Proteomics 13, 990–1007.
45. Yu, W, Liu, C, Li, X, et al. (2017) Inositol hexaphosphate suppresses colorectal cancer cell proliferation via the Akt/GSK-3β/β-catenin signaling cascade in a 1,2-dimethylhydrazine-induced rat model. Eur J Pharmacol 805, 67–74.
46. Tan, S-J, Yu, C, Yu, Z, et al. (2016) High-fat enteral nutrition reduces intestinal mucosal barrier damage after peritoneal air exposure. J Surg Res 202, 77–86.
47. Xu, R, Lei, YH, Shi, J, et al. (2016) Effects of lactadherin on plasma D-lactic acid and small intestinal MUC2 and claudin-1 expression levels in rats with rotavirus-induced diarrhea. Exp Ther Med 11, 943–950.
48. Bein, A, Zilbershtein, A, Golosovsky, M, et al. (2017) LPS induces hyper-permeability of intestinal epithelial cells. J Cell Physiol 232, 381–390.
49. Grivennikov, SI, Wang, K, Mucida, D, et al. (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254–258.
50. Sánchez de Medina, F, Romero-Calvo, I, Mascaraque, C, et al. (2014) Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis 20, 2394–2404.
51. Cholewa, K, Parfiniewicz, B, Bednarek, I, et al. (2008) The influence of phytic acid on TNF-alpha and its receptors genes’ expression in colon cancer Caco-2 cells. Acta Pol Pharm 65, 75–79.
52. Kapral, M, Wawszczyk, J, Sosnicki, S, et al. (2015) Down-regulation of inducible nitric oxide synthase expression by inositol hexaphosphate in human colon cancer cells. Acta Pol Pharm 72, 705–711.
53. Shafie, NH, Mohd Esa, N, Ithnin, H, et al. (2013) Preventive inositol hexaphosphate extracted from rice bran inhibits colorectal cancer through involvement of Wnt/β-catenin and COX-2 pathways. Biomed Res Int 2013, 1–10.